Enterprise Value
51.02M
Cash
15.21M
Avg Qtr Burn
-12.12M
Short % of Float
10.15%
Insider Ownership
0.89%
Institutional Own.
66.07%
Qtr Updated
12/31/23
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
BT-600 Details Inflammatory bowel disease, Ulcerative colitis | Phase 1 Data readout |